| |
| |
|
| Insider
Information: |
Oneil Thomas P. |
| Relationship: |
Chief Financial Officer |
| City: |
Davis |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,560 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$781,114 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,560 |
|
|
| Total
Value |
$781,114 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protagonist Therapeutics, Inc |
PTGX |
Chief Financial Officer |
2018-08-15 |
30,560 |
2017-12-18 |
0 |
Premium* |
|
|
Satsuma Pharmaceuticals, Inc. |
STSA |
Chief Financial Officer |
2023-06-06 |
0 |
2020-03-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2023-06-06 |
4 |
D |
$0.91 |
$12,628 |
D/D |
(13,877) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-09-01 |
4 |
AS |
$22.19 |
$16,645 |
D/D |
(750) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-09-01 |
4 |
OE |
$4.56 |
$3,420 |
D/D |
750 |
750 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-08-05 |
4 |
AS |
$25.00 |
$25,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-08-05 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-07-01 |
4 |
AS |
$25.63 |
$26,654 |
D/D |
(1,000) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-07-01 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
306 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-06-23 |
4 |
AS |
$35.23 |
$74,512 |
D/D |
(2,115) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-06-23 |
4 |
OE |
$1.04 |
$2,200 |
D/D |
2,115 |
2,115 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-06-01 |
4 |
AS |
$25.32 |
$25,324 |
D/D |
(1,000) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-06-01 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-05-20 |
4 |
AS |
$25.00 |
$50,000 |
D/D |
(2,000) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-05-20 |
4 |
OE |
$4.56 |
$9,120 |
D/D |
2,000 |
2,000 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-03-11 |
4 |
AS |
$27.68 |
$27,678 |
D/D |
(1,000) |
0 |
0 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
Chief Financial Officer |
• – – |
2020-03-11 |
4 |
OE |
$4.56 |
$4,560 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
21,100 |
30,560 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
8,858 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2017-12-18 |
4 |
AS |
$20.00 |
$160,000 |
D/D |
(8,000) |
0 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Chief Financial Officer |
• – – |
2017-12-18 |
4 |
OE |
$1.16 |
$21,480 |
D/D |
8,000 |
8,000 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
